Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00470145 | Comparison Of Two Tablet Formulations Of SB-568859 | PHASE1 | COMPLETED | 28 | — | — | Apr 1, 2007 | Jul 1, 2007 | Jun 4, 2012 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| SB-568859 | DRUG | - |
Inclusion Criteria: * Healthy men and sterile women between 18 and 50 years old * Body weight greater than 50 pounds and a body mass index between 19 and 31 * Normal electrocardiogram Exclusion criteria: * No history of asthma or severe allergic reactions * No history of or current drug use * No ...